Exercise Into Pain in Subacromial Shoulder Pain

Sponsor
Universiteit Antwerpen (Other)
Overall Status
Recruiting
CT.gov ID
NCT04553289
Collaborator
University of Malaga (Other), Rotterdam University of Applied Sciences (Other), University of Southern Denmark (Other)
54
1
2
27.1
2

Study Details

Study Description

Brief Summary

The aim of the randomized clinical trial is to investigate if "exercising into pain" gives better results in term of clinical outcomes compared to a non-painful exercise program.

Condition or Disease Intervention/Treatment Phase
  • Other: exercising into pain
  • Other: exercising with no/slight pain
N/A

Detailed Description

Exercise therapy is the first choice of treatment in the treatment of subacromial shoulder pain (SSP). Guidelines suggest exercise therapy for at least three months and research underlines the importance of progressive loaded exercise therapy at high dosage. However, it is not clear which is the best type of exercise and if pain should be provoked or avoided during exercise. Recent research found that painful exercises are beneficial in short term on pain and function in patients with different kinds of chronic musculoskeletal pain. The aim is to investigate if one painful exercise can give better and faster results in the management of SSP than non-painful program.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
54 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Exercise Into Pain in Subacromial Shoulder Pain: a Randomized Controlled Trial
Actual Study Start Date :
Aug 27, 2020
Anticipated Primary Completion Date :
Nov 30, 2022
Anticipated Study Completion Date :
Nov 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: exercising into pain

The participants will train during 12 with progressive loaded exercises, three times per week. There are 9 sessions of supervised physiotherapy treatment, lasting 30 minutes, while the rest of the sessions is conducted as home exercises. There are 4 strengthening exercises, including 2 in closed kinetic chain exercises and 2 executed with the elastic band or with dumbbell/weight. One exercise will be performed with pain ranging between 4 and 7 on a NPRS (Numeric Pain Rating Scale) and the rest of the exercises will be performed with no/slight pain, ranging between 0 and 2 on NPRS. At week 9, patients will continue to exercise with pain between 0 and 2 in all exercises. 10/15 minutes of manual therapy (posterior capsular release) will be applied during the physiotherapy session.

Other: exercising into pain
the intervention consists in 4 strength exercises: one will be performed into pain (ranging between 4 and 7 on NPRS scale) and the rest between 0 adn 2 on a NPRS scale

Active Comparator: exercising with no/slight pain

The participants will train during 12 weeks with progressive loaded exercises, three times per week. There are 9 sessions of supervised physiotherapy treatment, lasting 30 minutes, while the rest of the sessions is conducted as home exercises. There are 4 strengthening exercises, including 2 in closed kinetic chain exercises and 2 executed with the elastic band or with dumbbell/weight. All the exercises will be performed with no/slight pain, ranging between 0 and 2 on NPRS. 10/15 minutes of manual therapy (posterior capsular release) will be applied during the physiotherapy session.

Other: exercising with no/slight pain
the intervention consists in 4 strength exercises and all of them will be performed in no pain/slight pain (between 0 and 2 on NPRS scale)

Outcome Measures

Primary Outcome Measures

  1. Shoulder Pain and Disability Index (SPADI) [Change from baseline to 12 weeks]

    There are 13 items, divided in two subscales: pain (5 items) and function (8 items). Each item is scored from 0 (no pain/no difficulty) to 10 (worst imaginable pain/so difficult it requires help) on a NPRS. The final score is a percentage derived from an average of the two subscales, where higher score means worse outcome.

Secondary Outcome Measures

  1. Shoulder Pain and Disability Index (SPADI) [Change from baseline to 6 months]

    There are 13 items, divided in two subscales: pain (5 items) and function (8 items). Each item is scored from 0 (no pain/no difficulty) to 10 (worst imaginable pain/so difficult it requires help) on a NPRS. The final score is a percentage derived from an average of the two subscales, where higher score means worse outcome.

  2. Visual Analogue Scale (VAS) [Change from baseline to 12 weeks]

    It measures pain at rest, during activity, during night, in the past 24 hours. It is measured on a scale from 0 to 100, where 0=no pain, 100=worst imaginable pain.

  3. Visual Analogue Scale (VAS) [Change from baseline to 6 months]

    It measures pain at rest, during activity, during night, in the past 24 hours. It is measured on a scale from 0 to 100, where 0=no pain, 100=worst imaginable pain.

  4. Health-Related Quality of Life [Change from baseline to 12 weeks]

    It is measured with: 1) EQ-5D-5L (EuroQol-5 dimentions-5 levels) index: score range from less than 0 (0=value of health state equivalent to dead; negative values indicate state worse than dead) to 1 (the value of full health), with higher scores indicating higher health; 2) EQ-5D VAS (EuroQol-5 dimentions-Visual Analogue Scale), from 0 to 100 score, with 0=lowest health-related quality of life, 100=best health-related quality of life)

  5. Health-Related Quality of Life [Change from baseline to 6 months]

    It is measured with: 1) EQ-5D-5L (EuroQol-5 dimentions-5 levels) index: score range from less than 0 (0=value of health state equivalent to dead; negative values indicate state worse than dead) to 1 (the value of full health), with higher scores indicating higher health; 2) EQ-5D VAS (EuroQol-5 dimentions-Visual Analogue Scale), from 0 to 100 score, with 0=lowest health-related quality of life, 100=best health-related quality of life)

  6. Fear-Avoidance Beliefs Questionnaire (FABQ) [Change from baseline to 12 weeks]

    It consists of 16 items and it has 2 subscales: Physical Activity (FABQ-PA, range: 0-24) and Work (FABQ-W, range: 0-42) higher scores mean more fear avoidance beliefs affecting physical activity and/or work.

  7. Fear-Avoidance Beliefs Questionnaire (FABQ) [Change from baseline to 6 months]

    It consists of 16 items and it has 2 subscales: Physical Activity (FABQ-PA, range: 0-24) and Work (FABQ-W, range: 0-42) higher scores mean more fear avoidance beliefs affecting physical activity and/or work.

  8. Fear of Pain Questionnaire (FPQ-9) [Change from baseline to 12 weeks]

    It is a shortened version of the Fear of Pain Questionnaire-III. The total score ranges between 9 and 45; higher scores mean more fear and anxiety associated with pain.

  9. Fear of Pain Questionnaire (FPQ-9) [Change from baseline to 6 months]

    It is a shortened version of the Fear of Pain Questionnaire-III. The total score ranges between 9 and 45; higher scores mean more fear and anxiety associated with pain.

  10. Range of Movement (ROM) in internal rotation, external rotation, scaption [Change from baseline to 12 weeks]

    It is measured with the inclinometer. The unit of measure is degrees.

  11. Range of Movement (ROM) in internal rotation, external rotation, scaption [Change from baseline to 6 months]

    It is measured with the inclinometer. The unit of measure is degrees.

  12. Maximum Voluntary Contraction (MVC) in internal rotation, external rotation, scaption [Change from baseline to 12 weeks]

    It is measured with the Hand-Held Dynamometer. The unit of measure is Newtons.

  13. Maximum Voluntary Contraction (MVC) in internal rotation, external rotation, scaption [Change from baseline to 6 months]

    It is measured with the Hand-Held Dynamometer. The unit of measure is Newtons.

  14. Scapular Dyskinesis [Change from baseline to 12 weeks]

    It is measured with visual observation at rest and during movement (loaded and unloaded, in abduction and in flexion); the presence of winging, tilting or abnormal scapular movement determines the judgement about scapular dyskinesis (yes/no) at rest and during movement

  15. Scapular Dyskinesis [Change from baseline to 6 months]

    It is measured with visual observation at rest and during movement (loaded and unloaded, in abduction and in flexion); the presence of winging, tilting or abnormal scapular movement determines the judgement about scapular dyskinesis (yes/no) at rest and during movement

  16. Scapular Correction [Change from baseline to 12 weeks]

    it is measured with the reduction of symptoms during 2 tests: 2) the scapular assistance test (SAT); if the pain reduces after the SAT, the test is considered positive; 3) scapular retraction test (SRT); if the pain reduces after the SRT, the test is considered positive.

  17. Scapular Correction [Change from baseline to 6 months]

    it is measured with the reduction of symptoms during 2 tests: 2) the scapular assistance test (SAT); if the pain reduces after the SAT, the test is considered positive; 3) scapular retraction test (SRT); if the pain reduces after the SRT, the test is considered positive.

  18. Acromiohumeral Distance [Change from baseline to 12 weeks]

    it is measured with the Ultrasound at 0 and 60 degrees of elevation in the scapular plane (in millimeters)

  19. Acromiohumeral Distance [Change from baseline to 6 months]

    it is measured with the Ultrasound at 0 and 60 degrees of elevation in the scapular plane (in millimeters)

  20. Coracohumeral distance [Change from baseline to 12 weeks]

    it is measured with the Ultrasound at 0 and 60 degrees of elevation in the scapular plane (in millimeters)

  21. Coracohumeral distance [Change from baseline to 6 months]

    it is measured with the Ultrasound at 0 and 60 degrees of elevation in the scapular plane (in millimeters)

  22. Supraspinatus Tendon Thickness [Change from baseline to 12 weeks]

    it is measured with the Ultrasound in Crass position (in millimeters)

  23. Supraspinatus Tendon Thickness [Change from baseline to 6 months]

    it is measured with the Ultrasound in Crass position (in millimeters)

  24. Subscapularis Tendon Thickness [Change from baseline to 12 weeks]

    it is measured with the Ultrasound in maximal external rotation (in millimeters)

  25. Subscapularis Tendon Thickness [Change from baseline to 6 months]

    it is measured with the Ultrasound in maximal external rotation (in millimeters)

Other Outcome Measures

  1. Global perceived effect (GPE) [12 weeks]

    It is measured on a 7-Likert Scale, ranging from 1 (way much better) to 7 (way much worse); higher scores mean worst global perceived effect.

  2. Adherence [12 weeks]

    It is analysed in terms of attendance to the physiotherapist-led sessions and adherence to the home-exercise protocol. Good level of adherence is defined by: attendance of 7/9 (80%) of physiotherapist led-sessions and 22/27 (80%) days of home-exercises completed.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • shoulder pain for at least 3 months, elicited in the anterolateral shoulder region

  • at least 3 out of 5 of the following tests positive: Neer test, Hawkins-Kennedy, Jobe, painful arc, external resistance test

  • resting pain should be at 2/10 maximum on VAS scale

Exclusion Criteria:
  • corticosteroid injections 6 weeks prior to the study

  • pregnancy, inability to understand spoken or written Dutch

  • clinical signs of full-thickness rotator cuff tears (positive external and internal rotation lag tests and drop arm test)

  • bilateral shoulder pain

  • evidence of adhesive capsulitis

  • history of shoulder surgery, fracture or dislocation (on the painful shoulder)

  • primary complaint of spinal pain or signs of central nervous system involvement or signs of cervical nerve root involvement; reproduction of shoulder pain with cervical rotation or axial compression

  • primary diagnosis of acromioclavicular pathology, shoulder instability

  • a radiologically confirmed fracture or previous medical imaging confirming the presence of calcification larger than 5 mm

  • presence of competing pathologies (inflammatory arthritis, neurological disorders, fibromyalgia, malignancy, psychiatric illness, osteoporosis, haemophilia, rheumatic polymyalgia)

  • more than 4h of training in sport overhead shoulder activities per week

Contacts and Locations

Locations

Site City State Country Postal Code
1 Physiotherapy private practices Antwerp Belgium

Sponsors and Collaborators

  • Universiteit Antwerpen
  • University of Malaga
  • Rotterdam University of Applied Sciences
  • University of Southern Denmark

Investigators

  • Principal Investigator: Filip Struyf, Professor, Universiteit Antwerpen

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Filip Struyf, Professor, Universiteit Antwerpen
ClinicalTrials.gov Identifier:
NCT04553289
Other Study ID Numbers:
  • 18/34/379 (RCT)
First Posted:
Sep 17, 2020
Last Update Posted:
Jun 1, 2022
Last Verified:
May 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Filip Struyf, Professor, Universiteit Antwerpen
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 1, 2022